A Glimpse into DOJ’s New Health Care Enforcement Initiative

Law360

Melissa L. Jampol, a Member of the Firm in the Health Care and Life Sciences and Litigation practices, in the firm’s New York office, and George B. Breen, a Member of the Firm in the Health Care and Life Sciences and Litigation practices and Chair of the firm’s National Health Care and Life Sciences Practice Steering Committee, in the firm’s Washington, DC, office, co-authored an article in Law360, titled “A Glimpse into DOJ’s New Health Care Enforcement Initiative.” (Read the full version – subscription required.)

Following is an excerpt:

On July 13, 2017, the U.S. Department of Justice announced to great fanfare its eighth annual national health care fraud “takedown.” This “largest ever” “takedown” is not what many might imagine — swat teams of law enforcement agents simultaneously rounding up suspects around the country. Rather, it was a press event at Main Justice in Washington, D.C., that highlighted recent, mostly criminal, actions taken by federal and state authorities on a broad array of health care-related cases. Some of the matters are completely new investigations and prosecutions; while others stem from previously charged criminal cases.

Peeling back the layers of hyperbole, the “takedown” provides a helpful window into current health care-related investigative priorities of the DOJ, U.S. Department of Health and Human Services Office of Inspector General and FBI. The key takeaways include…